Sachetta’s Apellis Pharmaceuticals APLS Stock Holding History

Sachetta’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60	Closed	-$2.41K	–	1043
2026 Q1	$2.41K	Hold	60	–	–	﹤0.01%	849
2025 Q4	$1.51K	Hold	60	–	–	﹤0.01%	842
2025 Q3	$1.36K	Hold	60	–	–	﹤0.01%	917
2025 Q2	$1.04K	Buy	+60	New	+$1.11K	﹤0.01%	968
2025 Q1	–	Sell	-82	Closed	-$2.62K	–	1122
2024 Q4	$2.62K	Buy	82 +54	+193%	+$1.62K	﹤0.01%	761
2024 Q3	$808	Sell	28 -55	-66%	-$2.04K	﹤0.01%	1066
2024 Q2	$3.26K	Buy	83 +33	+66%	+$1.49K	﹤0.01%	702
2024 Q1	$2.99K	Hold	50	–	–	﹤0.01%	634
2023 Q4	$2.99K	Buy	+50	New	+$2.54K	﹤0.01%	634

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta's APLS Position: Q2 2026 in Review

Sachetta sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 60 shares — an estimated $2.41K sold.

Sachetta first reported a position in APLS in Q4 2023 and held it in 9 quarters. The position peaked at $3.26K in Q2 2024. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Sachetta reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Sachetta sold 60 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.41K.
Sachetta first reported a position in Apellis Pharmaceuticals in Q4 2023 and held it in 9 quarters.
Sachetta's Apellis Pharmaceuticals position peaked at $3.26K in Q2 2024.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.